Planned stock sale by Alignment Healthcare (ALHC) human resources chief

Rhea-AI Filing Summary

Alignment Healthcare, Inc. reported that Chief Human Resources Officer Andreas P. Wagner sold 21,118 shares of common stock in an open-market transaction on March 4, 2026 at a weighted-average price of $18.6216 per share.

The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2025, with individual trade prices ranging from $18.47 to $18.89 per share. Following this transaction, Wagner directly owns 148,687 Alignment Healthcare shares.

Insider Trade Summary

Net Seller: 21,118 shares ($393,251)

Net Sell 1 txn

Insider Wagner Andreas P.

Role Chief Human Resources Officer

Sold 21,118 shs ($393K)

Type	Security	Shares	Price	Value
Sale	Common Stock	21,118	$18.6216	$393K

Holdings After Transaction: Common Stock — 148,687 shares (Direct)

Footnotes (1)

1. Date of Rule 10b5-1 plan adoption: 11/21/2025 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $18.47 to $18.89. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wagner Andreas P.

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CA 92868

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Human Resources Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/04/2026		S(1)		21,118	D	$18.6216(2)	148,687	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Date of Rule 10b5-1 plan adoption: 11/21/2025

2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $18.47 to $18.89. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Andreas P. Wagner	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Alignment Healthcare (ALHC) disclose?

Alignment Healthcare disclosed an insider stock sale by a senior executive. Chief Human Resources Officer Andreas P. Wagner sold 21,118 shares of common stock in an open-market transaction at a weighted-average price of $18.6216 per share, as reflected in a recent Form 4 filing.

How many ALHC shares did Andreas P. Wagner sell and at what price?

Andreas P. Wagner sold 21,118 Alignment Healthcare shares. The common stock sale occurred at a weighted-average price of $18.6216 per share, with individual trade prices ranging from $18.47 to $18.89, according to the Form 4 footnote disclosures.

Does the ALHC insider sale involve a Rule 10b5-1 trading plan?

Yes, the ALHC insider sale was made under a Rule 10b5-1 plan. The filing notes the trading plan was adopted on November 21, 2025, indicating the transactions were pre-arranged rather than discretionary trades timed in response to short-term market developments.

How many Alignment Healthcare (ALHC) shares does Wagner hold after the sale?

After the reported sale, Wagner holds 148,687 ALHC shares directly. This post-transaction ownership figure reflects his remaining common stock position as reported in the Form 4, showing he continues to maintain a significant equity stake in Alignment Healthcare.

Who is the insider involved in the latest ALHC Form 4 filing?

The insider is Andreas P. Wagner, Alignment Healthcare’s Chief Human Resources Officer. He is reported as an officer of the company, not a director or 10% owner, and executed an open-market sale of company common stock under a Rule 10b5-1 plan.